GoodRx Care vs Novi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Novi beats GoodRx Care overall, scoring 7.8/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $133/mo. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side comparison of GoodRx Care and Novi covering pricing, scores, medication types, insurance, and more to help you decide.
GoodRx Care
#46 of 46GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.
Visit GoodRx CareNovi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit Novi| Feature | GoodRx Care | Novi |
|---|---|---|
| Our Score | 6.2/10 | 7.8/10 |
| Starting Price | $119/mo | $133/mo |
| Medication Type | Brand | Compounded |
| Insurance Accepted | Yes | No |
| Best For | Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing — $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer |
| Ranking | #46 | #14 |
Pros & Cons Compared
GoodRx Care
Pros
- +2026 subscription rewrite — $119/mo standard membership with medication priced among the lowest on the market
- +Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
- +Oral Wegovy pill available at $149-199/mo — one of the cheapest oral semaglutide routes
- +Insurance accepted — GoodRx's integration with savings cards can stack with coverage
Cons
- −Model changed from pay-per-visit to subscription — users expecting à-la-carte pricing should double-check current terms
- −Compounded GLP-1s are de-emphasized on current marketing — may no longer be available
- −Subscription model means ongoing monthly fee even in maintenance months
- −Follow-up clinical care is still basic compared to dedicated GLP-1 platforms
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Our Verdict
Novi edges out GoodRx Care with a score of 7.8/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to Novi's $133/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing — $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.